Search Results 1141-1150 of 8715 for Endemic

  1. Medical Research & Education - Mayo Clinic News Network

    Study shows daylight saving time has minimal effect on heart health featured image. Featured News ; Brain stimulation shows promise in treating drug addiction ...

  2. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic Comprehensive Cancer Center to highlight key studies at ASCO 2024. Kelley Luckstein. May 30, 2024. Mayo Clinic Minute: Benefits of an active ...

  3. A Study of Alisertib in Combination with Endocrine Therapy in Patients with HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer (ALISCA-Breast1) - Mayo Clinic

    A Study of Alisertib in Combination with Endocrine Therapy in Patients with HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer (ALISCA-Breast1).

  4. Publications - Benjamin H. Eidelman, M.D. - Mayo Clinic

    Hanna Al-Shaikh R, Czervionke L, Eidelman B, Dredla BK. Spinal Cord Infarction. StatPearls Treasure Island (FL) StatPearls Publishing 2025 Jan

  5. Clinical trials - Gastroenterology and Hepatology

    This study aims to facilitate discovery and validation of tests for early detection in subjects at high risk for pancreatic ductal adenocarcinoma (PDAC). and to ...

  6. Pulmonary Medicine Clinical Trials - Medical Professionals

    The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival (OS) ...

  7. Gastroenterology and Hepatology - Clinical trials

    The purpose of this study is to evaluate EUS-nCLE as an imaging biomarker and PCL fluid DNA analysis as a molecular biomarker for the management of pancreatic ...

  8. Relationship Between Nectin-4-Positive Exosomes in Blood and Urine and the Response to Enfortumab Vedotin Therapy - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. Rimegepant for the Treatment of Migraine (With or Without Aura) in Children and Adolescents ≥ 6 To < 18 Years of Age - Mayo Clinic

    This study is part of a broader pediatric development plan to evaluate rimegepant in the pediatric population. Acute treatment of migraine is a recognized ...

  10. Publications - Emily R. Levy, M.D. - Mayo Clinic

    Mitzelfelt JC, Hentz RC, Ristagno EH, Kanade R, Dinnes LM, Shah A, O'Horo J, Aganga DO, Levy ER. Standardizing Antimicrobial Prophylaxis in Pediatric ...